Drug Profile
GBL 100
Alternative Names: TB4SO; Thymosin beta 4 sulfoxideLatest Information Update: 06 Apr 2011
Price :
$50
*
At a glance
- Originator Grannus BioSciences
- Class
- Mechanism of Action Immunosuppressants; Neutrophil inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Psoriasis
Most Recent Events
- 06 Apr 2011 Discontinued - Phase-I for Psoriasis in United Kingdom (Topical)
- 20 Feb 2007 Phase-I clinical trials in Psoriasis in United Kingdom (Topical)